SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-077958
Filing Date
2021-03-11
Accepted
2021-03-11 17:14:00
Documents
19
Period of Report
2021-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d149566d8k.htm   iXBRL 8-K 30447
2 EX-1.1 d149566dex11.htm EX-1.1 245520
3 EX-4.1 d149566dex41.htm EX-4.1 75475
4 EX-5.1 d149566dex51.htm EX-5.1 9350
5 EX-10.1 d149566dex101.htm EX-10.1 31354
6 EX-99.1 d149566dex991.htm EX-99.1 8719
10 GRAPHIC g149566g0311223615751.jpg GRAPHIC 5522
11 GRAPHIC g149566g92k35.jpg GRAPHIC 4320
  Complete submission text file 0001193125-21-077958.txt   645677

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA svra-20210309.xsd EX-101.SCH 3081
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20210309_lab.xml EX-101.LAB 18907
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20210309_pre.xml EX-101.PRE 11870
12 EXTRACTED XBRL INSTANCE DOCUMENT d149566d8k_htm.xml XML 3518
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 21734222
SIC: 2834 Pharmaceutical Preparations